Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orli Even-Or

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|May 14, 2020
The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88Orli Even-Or, Shani Avniel-Polak, Yechezkel Barenholz, et al.
Expert Review of Vaccines|September 24, 2013
Adjuvanted influenza vaccinesOrli Even-Or, Sarit Samira, Ronald Ellis, et al.
Advanced Healthcare Materials|August 27, 2014
Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosisXue-Qing Zhang, Orli Even-Or, Xiaoyang Xu, et al.
Vaccine|April 24, 2010
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccineOrli Even-Or, Sarit Samira, Eli Rochlin, et al.
Vaccine|January 22, 2011
A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticityOrli Even-Or, Aviva Joseph, Noga Itskovitz-Cooper, et al.
Bioconjugate Chemistry|April 27, 2013
The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaquesAlessandra Barazza, Courtney Blachford, Orli Even-Or, et al.
Advanced Healthcare Materials|March 25, 2014
Development of therapeutic polymeric nanoparticles for the resolution of inflammationSuresh Gadde, Orli Even-Or, Nazila Kamaly, et al.
Circulation|August 24, 2013
Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasmaJoseph A DiDonato, Ying Huang, Kulwant S Aulak, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|May 14, 2020
The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88Orli Even-Or, Shani Avniel-Polak, Yechezkel Barenholz, et al.
Expert Review of Vaccines|September 24, 2013
Adjuvanted influenza vaccinesOrli Even-Or, Sarit Samira, Ronald Ellis, et al.
Advanced Healthcare Materials|August 27, 2014
Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosisXue-Qing Zhang, Orli Even-Or, Xiaoyang Xu, et al.
Vaccine|April 24, 2010
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccineOrli Even-Or, Sarit Samira, Eli Rochlin, et al.
Vaccine|January 22, 2011
A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticityOrli Even-Or, Aviva Joseph, Noga Itskovitz-Cooper, et al.
Bioconjugate Chemistry|April 27, 2013
The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaquesAlessandra Barazza, Courtney Blachford, Orli Even-Or, et al.
Advanced Healthcare Materials|March 25, 2014
Development of therapeutic polymeric nanoparticles for the resolution of inflammationSuresh Gadde, Orli Even-Or, Nazila Kamaly, et al.
Circulation|August 24, 2013
Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasmaJoseph A DiDonato, Ying Huang, Kulwant S Aulak, et al.
Pageof 1